HomeTag: ex vivo skin model

Tag: ex vivo skin model

Discover ISR Platform enhanced with AUDACY bioinformatics integration. Non-clinical local toxicity prediction for injection site reactions.
3
Oct

PRESS RELEASE – ImmunoSafe: ISR Platform®

By Alexandra Comments are Off , ,

Genoskin, a biotechnology company at the forefront of accelerating drug development, proudly announces the enhancement of its ISR Platform® with the integration of AUDACY, a state-of-the-art bioinformatics-based analytical solution. The new ImmunoSafe: ISR Platform® brings a transformative approach to assessing local toxicity in the realm of non-clinical platforms, specifically focusing on injection site reactions (ISR).

skin cancer spheroid in OncoSkin melanoma skin cancer models
26
May

Genoskin presents new skin cancer model at Meet2Win

By Genoskin Comments are Off , , , , ,

Genoskin launches new OncoSkin® skin cancer model at Meet2Win Genoskin has developed a new skin cancer model for the in vitro study of melanoma. Patients who suffer from this highly dangerous type of skin cancer currently have limited therapeutic options when the cancer reaches metastasis. The OncoSkin® skin cancer model now enables in vitro studies on live melanoma spheroids implanted

Read more